October 09, 2020
2 min watch
Save
VIDEO: LungART data ‘redefines’ treatment of patients with resected NSCLC
You've successfully added to your alerts. You will receive an email when new content is published.
Click Here to Manage Email Alerts
Click Here to Manage Email Alerts
We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com.
In this video, Jyoti D. Patel, MD, associate vice chair for clinical research and professor of medicine at Northwestern’s Feinberg School of Medicine, spoke with Healio about data from a phase 3 study in lung cancer included in the ESMO Virtual Congress 2020 presidential symposium.
“This is a trial that is practice-changing,” Patel said. “It will redefine how we treat patients with resected disease.”
References:
- Le Pechoux C, et al. Abstract LBA3_PR. Presented at: European Society for Medical Oncology Virtual Congress 2020; Sept. 19-21, 2020.
Published by:
Sources/Disclosures
Collapse
Source:
Healio Interview
Disclosures:
Patel reports serving as a consultant for Astra Zeneca, AbbVie, Genentech and Takeda, and receiving research funding to her institution from Bristol-Meyer Squibb.
Read more about
You've successfully added to your alerts. You will receive an email when new content is published.
Click Here to Manage Email Alerts
Click Here to Manage Email Alerts
We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com.